92 related articles for article (PubMed ID: 24382738)
1. Moving toward disease modification in polycythemia vera.
Bewersdorf JP; How J; Masarova L; Bose P; Pemmaraju N; Mascarenhas J; Rampal RK
Blood; 2023 Nov; 142(22):1859-1870. PubMed ID: 37729609
[TBL] [Abstract][Full Text] [Related]
2. Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis.
Chen CC; Chen JL; Lin AJ; Yu LH; Hou HA
Ann Hematol; 2024 Jun; 103(6):1947-1965. PubMed ID: 38652240
[TBL] [Abstract][Full Text] [Related]
3. Updated threshold, renewed problems: should the diagnostic criteria of polycythemia vera be reconsidered? A retrospective cross-sectional cohort study.
Uçan A; Özgeyik MO
Rev Assoc Med Bras (1992); 2024; 70(1):e20230497. PubMed ID: 38511749
[TBL] [Abstract][Full Text] [Related]
4. A case report and literature review of IgA nephropathy presenting as nephrotic syndrome in polycythemia vera.
Rajasekar R; Nandakumar R; Singhvi SP; Mathew GG; Jayaprakash V; Mythili K
CEN Case Rep; 2024 Apr; ():. PubMed ID: 38643434
[TBL] [Abstract][Full Text] [Related]
5. Prostatic metastases and polycythemia vera on bone magnetic resonance imaging: A case report.
Li Y; An W; Wei W; Liu M; Wang G; Wang X
Oncol Lett; 2015 Mar; 9(3):1317-1320. PubMed ID: 25663905
[TBL] [Abstract][Full Text] [Related]
6. In silico trial for the assessment of givinostat dose adjustment rules based on the management of key hematological parameters in polycythemia vera patients.
Tosca EM; De Carlo A; Bartolucci R; Fiorentini F; Di Tollo S; Caserini M; Rocchetti M; Bettica P; Magni P
CPT Pharmacometrics Syst Pharmacol; 2024 Mar; 13(3):359-373. PubMed ID: 38327117
[TBL] [Abstract][Full Text] [Related]
7. Oral hyperpigmentation associated with hydroxyurea in a patient with polycythemia vera: A case report.
Alshammasi B; Albasry Z; Meshikhes F
Clin Case Rep; 2020 Oct; 8(10):1904-1909. PubMed ID: 33088516
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient status.
Shrestha R; Sakata-Yanagimoto M; Maie K; Oshima M; Ishihara M; Suehara Y; Fukumoto K; Nakajima-Takagi Y; Matsui H; Kato T; Muto H; Sakamoto T; Kusakabe M; Nannya Y; Makishima H; Ueno H; Saiki R; Ogawa S; Chiba K; Shiraishi Y; Miyano S; Mouly E; Bernard OA; Inaba T; Koseki H; Iwama A; Chiba S
Blood Adv; 2020 Mar; 4(5):845-854. PubMed ID: 32126143
[TBL] [Abstract][Full Text] [Related]
9. The H3K4 methyltransferase Setd1b is essential for hematopoietic stem and progenitor cell homeostasis in mice.
Schmidt K; Zhang Q; Tasdogan A; Petzold A; Dahl A; Arneth BM; Slany R; Fehling HJ; Kranz A; Stewart AF; Anastassiadis K
Elife; 2018 Jun; 7():. PubMed ID: 29916805
[TBL] [Abstract][Full Text] [Related]
10. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
11. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
Bellucci S; Michiels JJ
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
[TBL] [Abstract][Full Text] [Related]
12. Complex karyotype in a polycythemia vera patient with a novel SETD1B/GTF2H3 fusion gene.
Tiziana Storlazzi C; Pieri L; Paoli C; Daniele G; Lasho T; Tefferi A; Vannucchi AM
Am J Hematol; 2014 Apr; 89(4):438-42. PubMed ID: 24382738
[TBL] [Abstract][Full Text] [Related]
13. Current diagnostic criteria for the chronic myeloproliferative disorders (MPD) essential thrombocythemia (ET), polycythemia vera (PV) and chronic idiopathic myelofibrosis (CIMF).
Michiels JJ; Bernema Z; Van Bockstaele D; De Raeve H; Schroyens W
Pathol Biol (Paris); 2007 Mar; 55(2):92-104. PubMed ID: 16919893
[TBL] [Abstract][Full Text] [Related]
14. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
[TBL] [Abstract][Full Text] [Related]
15. Studies of the bone marrow in polycythemia vera and the evolution of myelofibrosis and second hematologic malignancies.
Ellis JT; Peterson P; Geller SA; Rappaport H
Semin Hematol; 1986 Apr; 23(2):144-55. PubMed ID: 3704666
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
